AP1-Luc/EF1α-mCherry Reporter Cell Line - A549

AP1-Luc/EF1α-mCherry Reporter Cell Line - A549 is a human lung adenocarcinoma cell-based reporter system designed for sensitive monitoring of activator protein-1 (AP-1) transcriptional activity. The parental A549 cell line is widely used in respiratory biology, inflammation, oncology, and toxicology research. In this engineered line, firefly luciferase expression is driven by an AP-1-responsive promoter, enabling quantitative measurement of AP-1 pathway activation through luminescence detection. The cells also constitutively express mCherry under the human EF1α promoter, providing a stable fluorescent marker for cell identification, imaging, cell tracking, and assessment of culture consistency. AP-1 is a dimeric transcription factor complex primarily composed of members of the JUN, FOS, ATF, and MAF protein families. It functions as an important downstream regulator of signaling cascades such as MAPK/ERK, JNK, and p38, integrating extracellular stimuli including cytokines, oxidative stress, growth factors, and chemical exposure.

This reporter cell line is suitable for screening compounds that modulate AP-1-dependent signaling and for investigating the molecular mechanisms underlying inflammation, oxidative injury, cellular stress, proliferation, differentiation, and tumor progression. Luciferase activity offers a rapid, scalable, and quantitative endpoint for high-throughput or medium-throughput drug discovery campaigns, while mCherry fluorescence supports visual confirmation of cell localization, viability, and population distribution in live-cell assays. The model can evaluate pathway inhibitors or activators, characterize dose-response relationships, and compare the effects of candidate drugs, environmental agents, or biologics on AP-1 transcriptional regulation. It is also valuable for studying crosstalk between AP-1 and other signaling networks, including NF-κB, EGFR, and MAPK pathways.